Tuesday January 16th 2018

Archive for March, 2011

Out of the fog

Out of the fog

Music star Josh Groban owes Londoner Susan Skeffington about $7,000. Of course, she might just owe him a new chance at life. If Skeffington stays true to form, somehow the two will meet someday. The 45-year-old civilian worker for the London police force is nothing if not [Read More]

Forced to seek MS treatment in U.S

Forced to seek MS treatment in U.S

We just had the most amazing and successful fundraiser at the Fogolar Furlan for my husband, Barry Ashby. He suffers with multiple sclerosis (MS), has narrowed neck veins and goes to California on March 22 for the “Liberation Therapy” (CCSVI), unfortunately, not [Read More]

MS treatment care guidelines questioned

MS treatment care guidelines questioned

Support at home for those who have had controversial treatment for multiple sclerosis abroad is necessary, although local patients are skeptical that a new initiative will do the trick. A panel of doctors will develop guidelines for Ontario doctors to follow. It’s a [Read More]

 Page 3 of 6 « 1  2  3  4  5 » ...  Last » 

Latest Topics

FDA Denies Health Claim for Vitamin D to Prevent MS FDA Denies Health Claim for Vitamin D to Prevent MS

FDA Denies Health Claim for Vitamin D to Prevent MS FDA Denies Health Claim for Vitamin D to Prevent MS

The FDA responded to a petition, saying that after reviewing the evidence, there is no basis for the claim that vitamin [Read More]

Effects of sport climbing on multiple sclerosis – Steimer J, Weissert R.

Effects of sport climbing on multiple sclerosis – Steimer J, Weissert R.

Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS) with [Read More]

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the [Read More]

MS Drug Ocrelizumab (Ocrevus) Approved in Europe MS Drug Ocrelizumab (Ocrevus) Approved in Europe

MS Drug Ocrelizumab (Ocrevus) Approved in Europe MS Drug Ocrelizumab (Ocrevus) Approved in Europe

The European Commission clears the anti-CD20 monoclonal antibody for adults with relapsing multiple sclerosis and early [Read More]

New PET radiotracer offers insight into multiple sclerosis

New PET radiotracer offers insight into multiple sclerosis

Combining PET scans with a novel radiotracer could help researchers track damage...Read more on AuntMinnie.comRelated [Read More]